0001555667-15-000052.txt : 20150917 0001555667-15-000052.hdr.sgml : 20150917 20150917174341 ACCESSION NUMBER: 0001555667-15-000052 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150915 FILED AS OF DATE: 20150917 DATE AS OF CHANGE: 20150917 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SOLAZYME INC CENTRAL INDEX KEY: 0001311230 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 331077078 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 225 GATEWAY BLVD. CITY: S. SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-780-4777 MAIL ADDRESS: STREET 1: 225 GATEWAY BLVD. CITY: S. SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Licari Peter CENTRAL INDEX KEY: 0001353937 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35189 FILM NUMBER: 151113508 MAIL ADDRESS: STREET 1: 225 GATEWAY BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2015-09-15 0001311230 SOLAZYME INC SZYM 0001353937 Licari Peter SOLAZYME, INC. 225 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Technology Officer Common Stock 2015-09-15 4 S 0 1562 3.0818 D 173967 D Common Stock 2015-09-17 4 S 0 1562 3.1458 D 172405 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was designed to cover tax withholding obligations in connection with the concurrent vesting of restricted stock units. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.04 to $3.10, inclusive. The reporting person undertakes to provide to Solazyme, Inc., any security holder of Solazyme, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.12 to $3.17, inclusive. The reporting person undertakes to provide to Solazyme, Inc., any security holder of Solazyme, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. /s/ Rob Maynes, as attorney-in-fact 2015-09-17